ProCE Banner Activity

Long-Acting Lipoglycopeptides for Skin and Soft Tissue Infections: Implementation Into Practice

Podcast Episodes

Hear Kyle Molina, PharmD, BCIDP, discuss key considerations to ensure successful implementation of long-acting lipoglycopeptides for ABSSSI treatment into practice, such as justifying cost, targeting the right patient population, selecting between infusion locations, and maximizing institutional impact.

Released: August 08, 2023

Share

Faculty

Kyle Molina

Kyle Molina, PharmD, BCIDP

Infectious Diseases/Antomicrobial Stewardship Pharmacist
Department of Pharmacy
Scripps Green Hospital
La Jolla, California

Provided by

Provided by Clinical Care Options, LLC, in partnership with ProCE, LLC and the Society of Infectious Diseases Pharmacists (SIDP).

ProCE Banner

Supporters

Supported by an educational grant from Melinta Therapeutics.

Melinta Therapeutics

Partners

ProCE

ProCE Banner

Society of Infectious Diseases Pharmacists (SIDP)

ProCE Banner

Faculty Disclosure

Primary Author

Kyle Molina, PharmD, BCIDP

Infectious Diseases/Antomicrobial Stewardship Pharmacist
Department of Pharmacy
Scripps Green Hospital
La Jolla, California

Kyle Molina, PharmD, BCIDP: consultant: Melinta Therapeutics